EHP is vigilant against all forms of scientific misconduct, including misreported or undisclosed conflicts of interest for authors and reviewers alike; unethical research design; insufficient detail on patient consent or protection of research subjects, including animals; plagiarism; falsification or fabrication of data; and willful duplicate publication.
Misreporting or failure to report competing financial interests: EHP relies on the integrity of all authors to provide accurate disclosure statements. Authors can expect scrutiny of their statements by the editors, reviewers, and readership.
Plagiarism: All papers submitted to EHP are screened for plagiarism using the plagiarism detection service iThenticate. EHP considers plagiarism to be the presentation of words or ideas of others without a proper citation or credit. Similarly, self-plagiarism is the use of one’s own previously published text or data without a proper citation or permission to duplicate material copyrighted by the original publisher.
Data fabrication and falsification: Data fabrication is the intentional misrepresentation of results by creating false data and reporting them as genuine findings. Data falsification is the manipulation of research materials, equipment, or data, including alteration of images, removal of outliers or inconsistent results, and changing of data points.
Research involving animals: EHP requires assurances both during submission and in the “Methods” section of the manuscript that the protocol was approved by an institutional animal care and use committee.
Protection of human subjects: Research involving human subjects must have been conducted according to the Common Rule, and such studies must be approved by an appropriate institutional review board and comply with all relevant national, state, and local regulations. For research conducted outside the United States, authors must have performed the research in accordance with the principles of the Declaration of Helsinki. Approval and compliance with research requirements regarding human subjects must be noted, and information regarding informed consent procedures must be described in the “Methods” section of manuscripts concerning human subjects research.
EHP takes allegations of misconduct on the part of authors or reviewers very seriously and follows the guidelines of the Committee on Publication Ethics (COPE) for investigating and addressing allegations or suspicions of misconduct.
- EHP will impose a 3-year ban on publication in EHP for any author(s) found to have willfully engaged in misconduct. Additionally, the misconduct will be reported to the responsible authors’ host institution(s), and the relevant paper may be retracted or an Expression of Concern published and appended to the article.
- Substantiated cases of reviewer misconduct will be reported to the reviewer’s host institution, and the responsible reviewer will be banned from reviewing for EHP.
Suspicions of misconduct should be reported to: email@example.com.